TWI281861B - A pharmaceutical composition comprising SANORG 34006 for treatment and secondary prophylaxis of venous thromboembolic events in patients with deep venous thrombosis - Google Patents
A pharmaceutical composition comprising SANORG 34006 for treatment and secondary prophylaxis of venous thromboembolic events in patients with deep venous thrombosis Download PDFInfo
- Publication number
- TWI281861B TWI281861B TW092100703A TW92100703A TWI281861B TW I281861 B TWI281861 B TW I281861B TW 092100703 A TW092100703 A TW 092100703A TW 92100703 A TW92100703 A TW 92100703A TW I281861 B TWI281861 B TW I281861B
- Authority
- TW
- Taiwan
- Prior art keywords
- methyl
- treatment
- patients
- tri
- thio
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7024—Esters of saccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02075374 | 2002-01-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200302104A TW200302104A (en) | 2003-08-01 |
| TWI281861B true TWI281861B (en) | 2007-06-01 |
Family
ID=27635850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW092100703A TWI281861B (en) | 2002-01-29 | 2003-01-14 | A pharmaceutical composition comprising SANORG 34006 for treatment and secondary prophylaxis of venous thromboembolic events in patients with deep venous thrombosis |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7709463B2 (enExample) |
| EP (1) | EP1471924B1 (enExample) |
| JP (1) | JP4870907B2 (enExample) |
| CN (1) | CN1622813A (enExample) |
| AR (1) | AR038320A1 (enExample) |
| AT (1) | ATE323497T1 (enExample) |
| AU (1) | AU2003205664B2 (enExample) |
| BR (1) | BR0307196A (enExample) |
| CA (1) | CA2472957C (enExample) |
| CY (1) | CY1107661T1 (enExample) |
| DE (1) | DE60304678T2 (enExample) |
| DK (1) | DK1471924T3 (enExample) |
| EA (1) | EA007204B1 (enExample) |
| ES (1) | ES2262971T3 (enExample) |
| MX (1) | MXPA04007310A (enExample) |
| NO (1) | NO332699B1 (enExample) |
| PE (1) | PE20030855A1 (enExample) |
| PL (1) | PL207144B1 (enExample) |
| PT (1) | PT1471924E (enExample) |
| SI (1) | SI1471924T1 (enExample) |
| TW (1) | TWI281861B (enExample) |
| WO (1) | WO2003063881A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1831206B1 (en) * | 2004-12-01 | 2011-08-24 | OSI Pharmaceuticals, Inc. | N-substituted benzimidazolyl c-kit inhibitors and combinatorial benzimidazole library |
| US9642822B2 (en) * | 2011-05-27 | 2017-05-09 | Children's Medical Center Corporation | Methods for treating and preventing neutrophil-derived net toxicity and thrombosis |
| JP2022540849A (ja) | 2019-07-09 | 2022-09-20 | オプティムヴィア、エルエルシー | 抗凝固性多糖類の合成方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378829A (en) * | 1990-04-23 | 1995-01-03 | Akzo N.V. | Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type |
-
2003
- 2003-01-14 TW TW092100703A patent/TWI281861B/zh not_active IP Right Cessation
- 2003-01-23 AT AT03702514T patent/ATE323497T1/de active
- 2003-01-23 CA CA2472957A patent/CA2472957C/en not_active Expired - Fee Related
- 2003-01-23 AU AU2003205664A patent/AU2003205664B2/en not_active Ceased
- 2003-01-23 US US10/502,706 patent/US7709463B2/en not_active Expired - Fee Related
- 2003-01-23 ES ES03702514T patent/ES2262971T3/es not_active Expired - Lifetime
- 2003-01-23 EA EA200400817A patent/EA007204B1/ru not_active IP Right Cessation
- 2003-01-23 WO PCT/EP2003/000696 patent/WO2003063881A1/en not_active Ceased
- 2003-01-23 JP JP2003563570A patent/JP4870907B2/ja not_active Expired - Fee Related
- 2003-01-23 PL PL370557A patent/PL207144B1/pl unknown
- 2003-01-23 CN CNA038028123A patent/CN1622813A/zh active Pending
- 2003-01-23 MX MXPA04007310A patent/MXPA04007310A/es active IP Right Grant
- 2003-01-23 SI SI200330334T patent/SI1471924T1/sl unknown
- 2003-01-23 BR BR0307196-0A patent/BR0307196A/pt not_active Application Discontinuation
- 2003-01-23 DE DE60304678T patent/DE60304678T2/de not_active Expired - Lifetime
- 2003-01-23 DK DK03702514T patent/DK1471924T3/da active
- 2003-01-23 PE PE2003000071A patent/PE20030855A1/es not_active Application Discontinuation
- 2003-01-23 PT PT03702514T patent/PT1471924E/pt unknown
- 2003-01-23 EP EP03702514A patent/EP1471924B1/en not_active Expired - Lifetime
- 2003-01-28 AR ARP030100237A patent/AR038320A1/es not_active Application Discontinuation
-
2004
- 2004-07-27 NO NO20043195A patent/NO332699B1/no not_active IP Right Cessation
-
2006
- 2006-07-19 CY CY20061101002T patent/CY1107661T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL370557A1 (en) | 2005-05-30 |
| PL207144B1 (pl) | 2010-11-30 |
| CY1107661T1 (el) | 2013-04-18 |
| AR038320A1 (es) | 2005-01-12 |
| MXPA04007310A (es) | 2004-10-29 |
| US7709463B2 (en) | 2010-05-04 |
| JP2005519919A (ja) | 2005-07-07 |
| PE20030855A1 (es) | 2003-10-11 |
| EP1471924B1 (en) | 2006-04-19 |
| HK1072361A1 (en) | 2005-08-26 |
| WO2003063881A1 (en) | 2003-08-07 |
| JP4870907B2 (ja) | 2012-02-08 |
| SI1471924T1 (sl) | 2006-10-31 |
| NO20043195L (no) | 2004-10-29 |
| DE60304678T2 (de) | 2007-04-05 |
| CN1622813A (zh) | 2005-06-01 |
| CA2472957A1 (en) | 2003-08-07 |
| AU2003205664B2 (en) | 2008-06-05 |
| NO332699B1 (no) | 2012-12-10 |
| ES2262971T3 (es) | 2006-12-01 |
| TW200302104A (en) | 2003-08-01 |
| DE60304678D1 (de) | 2006-05-24 |
| CA2472957C (en) | 2011-09-13 |
| EP1471924A1 (en) | 2004-11-03 |
| EA007204B1 (ru) | 2006-08-25 |
| ATE323497T1 (de) | 2006-05-15 |
| BR0307196A (pt) | 2004-11-03 |
| DK1471924T3 (da) | 2006-08-21 |
| US20050209175A1 (en) | 2005-09-22 |
| PT1471924E (pt) | 2006-09-29 |
| EA200400817A1 (ru) | 2005-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lindmarker et al. | Comparison of once-daily subcutaneous Fragmin® with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis | |
| Luomanmäki et al. | A multicentre comparison of once‐daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis | |
| TR201808687T4 (tr) | Düşük vi̇zkozi̇teli̇ gli̇kosami̇nogli̇kanlardan oluşan bi̇leşi̇mler ve söz konusu bi̇leşi̇mi̇n, kroni̇k si̇sti̇t tedavi̇si̇nde kullanimi | |
| CN1758920A (zh) | 采用高剂量硫酸软骨素的膀胱炎疗法 | |
| TWI281861B (en) | A pharmaceutical composition comprising SANORG 34006 for treatment and secondary prophylaxis of venous thromboembolic events in patients with deep venous thrombosis | |
| Ownby et al. | In vivo ability of antimyotoxin a serum plus polyvalent (Crotalidae) antivenom to neutralize prairie rattlesnake (Crotalus viridis viridis) venom | |
| Wood et al. | Trial of aspirin and RA 233 in prevention of post-operative deep vein thrombosis | |
| WALLER et al. | The effect of probenecid on nafcillin disposition | |
| WO2003033004A1 (en) | Agents for treating inflammatory bowel diseases | |
| Abdel Salam et al. | Vinpocetine ameliorates acute hepatic damage caused by administration of carbon tetrachloride in rats | |
| Zucker et al. | Chemotherapy of tuberculosis: promin by the intravenous drip method | |
| CN1846737A (zh) | 一种治疗心脑血管疾病的药物及其制作方法 | |
| Dancey et al. | Promin in Pulmonary Tuberculosis, A Progress Report | |
| CN1064234C (zh) | 二咖啡酰氧基--奎宁酸在制药中的应用 | |
| JPH03501734A (ja) | ポドフィリンと組換えｄｎａヒト・アルファ・インターフェロンの併用による生殖器イボの治療 | |
| AU2003205664A1 (en) | Idraparinux(sanorg 34006)for treatment and secondary prophylaxis of venous thromboemolic events in patients with deep venous thrombosis | |
| CN1602197A (zh) | 特定剂量的Fondaparinux Sodi um在治疗急性冠状动脉综合征中的应用 | |
| Zakerian et al. | Effect of polyethylene glycol and senna bowel preparation in dogs on some hematological and serum biochemical parameters. | |
| JP2001354572A (ja) | 肝疾患処置剤 | |
| CN1065757C (zh) | 茶色素在制备治疗高尿酸血症的药物中的应用 | |
| Walenga et al. | Combined thrombin and platelet inhibition treatment for HIT patients | |
| ARE | Parallel infusion of hydrocortisone±chlorpheniramine bolus injection to prevent acute adverse reactions to antivenom for snakebites | |
| CN1430986A (zh) | 复方莪术油软膏及其制备方法 | |
| CN1682715A (zh) | 一种抗缺氧药物组合物 | |
| EP2192912B1 (en) | Essential oil of kunzea ambigua and methods of use |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |